TWM
DERM icon

TMD Wealth Management’s Journey Medical DERM Stock Holding History

TMD Wealth Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$65.5K Buy
+11,605
New +$47.8K 0.01% 55

Other funds holding DERM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

TMD Wealth Management's DERM Position: Q2 2024 in Review

TMD Wealth Management opened a new position in Journey Medical (DERM) in Q2 2024: 11,605 shares worth $65.5K. The stake represents 0.01% of the portfolio and ranks #55 among its holdings.

35 funds tracked by Wall St. Rank hold DERM as of Q2 2024.

  • TMD Wealth Management held 11,605 shares of Journey Medical worth $65.5K as of Q2 2024.
  • Journey Medical was a new TMD Wealth Management position in Q2 2024.
  • Journey Medical made up 0.01% of TMD Wealth Management's portfolio in Q2 2024, its #55 holding.
  • 35 funds tracked by Wall St. Rank held Journey Medical as of Q2 2024.

Based on TMD Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.